Check often for updates.

  • Last update 8/11/2020
  • We check instructions to identify any explicit prohibitions on applications from US academic institutions but we do not enter the application system or communicate with funders to confirm details.
Newest Additions (Week of 8/10/2020)

Directory:

National Institutes of Health Funding Opportunities
Other Federal Funding Opportunities
Foundations and Other Funding Opportunities
Challenges & Innovation Accelerator Competitions
Other COVID Funding Compilations

We update most items daily and also crowd-source information to aim for comprehensive representation of opportunities for those in US academic settings with breadth of disciplines. These are cross-checked weekly.

For details about the funding sources and compilations for which we conduct scheduled surveillance for funding opportunities, this is the working document enumerating sources and links: bit.ly/34HBOt8

Please suggest additions of funding opportunities in comments.

National Institutes of Health

General Communications for Awardees & Those Submitting Grants

NIH Administrative Supplements:

If you currently have an active NIH grant, you may be eligible to apply for an administrative supplement to support COVID-19 research. Administrative supplements are non-competing awards that provide additional funding to a currently funded grant to meet increased costs that are within the scope of the approved project. Contact program official to discuss. Parent funding opportunity is PA-18-591.

NIH Competitive Revisions:

Provide a path for an existing grant award to shift research priorities using the NIH Urgent Award Mechanism for a Public Health Crisis. The Urgent Award FOA (PA-18-935) enables a quick response to urgent public health needs. 

Common Fund – Office of Strategic Coordination

NIH Director’s Emergency Transformative Research Awards (R01 Clinical Trial Optional)
  • Due: September 4, 2020
  • Funding: Not specified
  • Project period: Up to 5 years
  • Purpose: To fund new perspectives and approaches to the prevention of, preparation for, or response to coronavirus SARS-CoV-2, domestically or internationally. Any relevant area of coronavirus SARS-CoV-2 research is welcome, including behavioral/social science research, research on health disparities, novel therapeutics. Innovation may be technological or conceptual.
NIH Director’s Emergency Early Independence Awards (DP5 Clinical Trial Optional)
  • Due: September 4, 2020
  • Funding: Up to $250,000
  • Project period: Up to 5 years
  • Purpose: To support exceptional junior investigators who wish to pursue independent research without the traditional post-doctoral training period. This call is for projects related to the COVID-19 public health emergency. Innovation may be technological or conceptual.
  • Eligibility Notes: Up to 2 applicants per institution.

Multiple NIH Institutes & Offices

(NIMHD, NIA, NIDA, NCI)
Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional)
  • First due date: October 5, 2020 (LOI Sept 4, 2020)
  • Funding: Not specified
  • Project period: Up to 5 years
  • Purpose: To support investigative and collaborative research focused on understanding the long-term effects of natural and/or man-made disasters on health care systems serving health disparity populations in communities in the U.S., including territories. COVID-19 is one example disaster.
(OD, NIMHD, NIA, NEI, NHGRI, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, FIC, NCCIH, NCATS, NCI)
Notice of Special Interest: Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
  • Due: September 8, 2020
  • Funding: Up to $400,000 per year, direct costs
  • Project period: Up to 2 years
  • Purpose: To identify, analyze, and address the social, ethical, and behavioral factors likely to influence access and uptake of COVID-19 testing in underserved and/or vulnerable populations.
(OD, NIMHD, NIA, NEI, NHGRI, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, FIC, NCCIH, NCATS, NCI)
Notice of Special Interest: Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
  • Due: September 8, 2020
  • Funding: Up to $1.3 M total (75% allocated to first year)
  • Project period: Up to 2 years
  • Purpose: To support supplements to individual NIH research awards that include community collaborations or partnerships to support COVID-19 testing (or have the capacity to ramp up quickly) to reach underserved and/or COVID-19 vulnerable populations.
(OBSSR, NIA, NIAAA, NIDDK, NIEHS, NCCIH, NCI, NICHD, NINR, NHGRI)
Notice of Special Interest: Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus & the Behavioral and Social Sciences
  • Due: Rolling through March 31, 2021
  • Funding: $100,000 direct costs per year
  • Project period: Up to 2 years
  • Purpose: To encourage supplements to existing longitudinal studies that address key social and behavioral questions related to the COVID-19 pandemic, including adherence to and transmission mitigation from various containment and mitigation efforts; social, behavioral, and economic impacts from these containment and mitigation efforts; and downstream health impacts resulting from these social, behavioral, and economic impacts, including differences in risk and resiliency based on gender, race and ethnicity, socioeconomic status, and other social determinants of health.
(OPPNET, NIA, NIAA, NICHD, NIDA, NIMH, NINDS, NINR, NIMHD, NCCIH)
Notice of Additional Due Date and Areas of Focus of “Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01)”
  • Due: March 17, 2021
  • Funding: Not specified
  • Project period: Up to 5 years
  • Purpose: To model the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in health, illness, recovery, and overall wellbeing. Notice adds specific interest in COVID-19 responses.
(NIMHD, NEI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIMH, NINR, NCCIH, NCATS)
Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)
  • Due: August 28, 2020 and December 1, 2020
  • Funding: Up to $500,000 direct costs annually
  • Project period: Up to 5 years
  • Purpose: To evaluate community interventions testing 1) the impacts of mitigation strategies to prevent COVID-19 transmission and acquisition; and 2) already implemented, new, or adapted interventions to address the adverse consequences of the pandemic on the health of these groups.
(NIMH, NCATS, NCCIH, NEI, NHLBI, NIA, NIAAA, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIMHD, NINR)
Notice of Special Interest: Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19
  • Due: Rolling through December 15, 2020
  • Funding: Up to $200,000 direct costs
  • Project period: 1 year (2 years with justification)
  • Purpose: To support research to address secondary health effects of the social, behavioral, and economic changes, particularly among populations who experience health disparities and vulnerable populations through the use of digital health assessments and interventions to yield measurable near-term impact.
(NIMHD, NEI, NHLBI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIMH, NCCIH, NCATS)
Notice of Special Interest: Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations
  • Due: Rolling through December 15, 2020
  • Funding: Up to $250,000 per year, direct costs
  • Project period: 1 year (2 years with justification)
  • Purpose: To test community interventions focused on the prevention (or slowing) of COVID-19 transmission, evaluate local and state policies and programs intended to mitigate COVID-19 exposure and improve adherence, and reduce the negative impact of the multifaceted consequences on the health of populations who experience health disparities and other vulnerable groups.
(OD, NHLBI, NHGRI, NIA, NIAID, NIAMS, NICHD, NIDCD, NIDCR, NIDDK, NIEHS, NINDS, NIMHS, NCCIH, NCATA, ORIP, NCI)
Notice of Special Interest: Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project
  • Due: November 12, 2020; March 12, 2021; July 12, 2021
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To improve understanding and treatment of COVID-19 infection in individuals with Down syndrome and reduce COVID-19 associated morbidity and mortality for this population.
(NIMH, NEI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDA, NINR, NIMHD, NCCIH, NCATS)
Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 – Clinical Trial Optional)
  • Due: August 20, 2020; December 2, 2020; March 2, 2021
  • Funding: Up to $750,000 per year, direct costs
  • Project period: Up to 3 years
  • Purpose: To determine the role and impact of digital health interventions to address secondary health effects of the social, behavioral, and economic changes following the COVID-19 pandemic, particularly among populations who experience health disparities and vulnerable populations.

National Cancer Institute (NCI)

Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be Redirected to COVID-19-related Research During the Crisis

National Center for Advancing Translational Sciences (NCATS)

Notice of Special Interest: Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address COVID-19 Public Health Needs
  • Due: Rolling through November 10, 2020
  • Funding: Varies by FOA
  • Project period: 1 year; up to 2 years with strong justfication
  • Purpose: To highlight need for addressing COVID-19 public health emergency within existing CTSA institutions. Specific focus varies by FOA.
Notice of Special Interest: New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need
  • Due: Rolling through November 10, 2020
  • Funding: Not specified
  • Project period: Up to 12 months
  • Purpose: To address the coronavirus disease 2019 (COVID-19) Public Health Emergency. Responsive activities vary by active award type.
Repurposing Existing Therapeutics to address COVID-19 (UG3, UH3, U34, U01)
  • Due: Variable dates in June and October 2020
  • Purpose: To repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed a Phase I clinical trial. The hypothesis for proposed studies must be developed using innovative processes to identify the therapeutic/indication pair. 
Limited Competitions (UL1/U01/U24/R21) to current CTSA awardees to address COVID-19 public health needs
  • Due: Variable dates through July 2021
  • Purpose: To use informatics solutions to diagnose cases and use CTSA-supported core resources (e.g., advanced scientific instruments, highly-specialized facilities, and regulatory expertise) to facilitate research on COVID-19 and advance the translation of research findings into diagnostics, therapeutics, and vaccines. 
Notice of Special Interest: Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus
  • Due: Rolling through January 25, 2022
  • Project period: 1 year
  • Purpose: To use microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection, and to advance the translation of research findings into diagnostics, therapeutics, and vaccines.
Notice of Special Interest: Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus
  • Due: Rolling through January 25, 2022
  • Purpose: To use microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection, and to advance the translation of research findings into diagnostics, therapeutics, and vaccines.

National Center for Complimentary and Integrative Health (NCCIH)

Notice of Special Interest: Administrative Supplements & Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19)
  • Due: Rolling through August 17, 2020
  • Funding: Up to $150,000 direct costs
  • Project period: Up to 1 year
  • Purpose: To rapidly establish scientific evidence and/or elucidate the mechanism of action of natural product–based remedies for SARS-CoV-2 and COVID-19. For active NCCIH grants.
Notice of Special Interest: Administrative Supplements & Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19)
  • Due: Rolling through October 6, 2020
  • Project period: Up to 2 years
  • Purpose: To research stress management strategies, including mind and body approaches, that individuals may engage in remotely to address stressors related to social distancing, as well as to address recovery and recurrence of symptoms during and after COVID-19 infections.

National Institute of Allergy & Infectious Diseases (NIAID)

NIAID COVID-19 research priorities
Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)
  • Due: Rolling until July 8, 2021
  • Funding: Reflect actual need
  • Project period: Up to 1 year
  • Purpose: To provide personal protective equipment to directly support the needs of the NIAID’s vaccine and treatment clinical trials for COVID-19. Eligibility is limited to clinical trials and clinical studies supported by NIAID’s emergency appropriation.
Notice of Special Interest: Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
  • Due: Rolling until July 2, 2021
  • Funding: Not more than annual amount of current parent award
  • Project period: Up to 2 years
  • Purpose: To increase and enhance select research efforts to facilitate the SARS-CoV-2/COVID-19 research response. Areas of interest are limited to: 1) current BSL3 facilities, 2) generation of critical reagents, 3) expansion of data systems, and 4) expansion of clinical trial infrastructure.
Notice of Special Interest: Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
  • Due: Standard dates until September 8, 2021
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To rapidly improve our understanding and available control measures for SARS-CoV-2 and COVID-19, including viral infection, replication, pathogenesis, and transmission; evolution and emergence of SARS-CoV-2 viruses; SARS-COV-2 therapeutic candidates; and more.
  • Note: Uses R03 (Clinical Trial Not Allowed), SBIR [R43/R44] (Clinical Trial Not Allowed), and Parent STTR [R41/R42] (Clinical Trial Not Allowed) mechanisms.
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed)
  • Due: Rolling through August 14, 2020
  • Funding: Up to $275,000 total costs
  • Project period: 2 years
  • Purpose: To provide an expedited funding mechanism for research on SARS-CoV-2 and/or Coronavirus Disease 2019 (COVID-19). 
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed)
  • Due: Rolling through August 14, 2020
  • Funding: Not specified
  • Project period: Up to 5 years
  • Purpose: To provide an expedited funding mechanism for research on SARS-CoV-2 and/or Coronavirus Disease 2019 (COVID-19).

National Institute of Biomedical Imaging & Bioengineering (NIBIB)

Notice of Special Interest: Small Business Research & Development of Biomedical Technologies for COVID-19
  • First due date: April 5, 2020
  • Purpose: To highlight urgent need for accelerating development, translation, and commercialization of technologies to address COVID-19. Seeking applications to develop life-saving technologies that can be ready for commercialization within one to two years. 
Notice of Special Interest: Development of Biomedical Technologies for COVID-19 
  • Due: Varied by award type (R01, R21, and R03)
  • Purpose: To highlight the urgent need for accelerating the development, translation, and commercialization of technologies to address COVID-19. Seeking applications to develop life-saving technologies that can be ready for commercialization within one to two years. 
Notice of Special Interest: Emergency Competitive Revision & Administrative Supplements on Biomedical Technologies for COVID-19 
  • Due: Rolling through November 10, 2020
  • Project period: 1 to 2 years
  • Purpose: To highlight urgent need for accelerating the development, translation, and commercialization of technologies to address COVID-19. Seeking applications to develop life-saving technologies that can be ready for commercialization within one to two years.
Rapid Acceleration of Diagnostics (RADx) – Fast-Track Program for COVID-19 Test Development and Distribution
  • Due: Rolling
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to  clinical laboratory tests, that can directly detect SARS-CoV-2. NIBIB will support the full range of product development including commercialization and product distribution.
  • Notes: Uses NIH Point-of-Care Technology Research Network. Apply through RADx portal.

National Institute of Dental and Craniofacial Research (NIDCR)

NIDCR has issued FAQs for the following Notices.
Notice of Special Interest: Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR
  • Due: November 2, 2020
  • Funding: Not to exceed $150,000 direct costs
  • Project period: 1 year
  • Purpose: To fund topics of immediate and high impact to protect and ensure the safety of personnel and patients in dental practices. Topics include prevention of SARS-COV-2 transmission and improvements in the detection and diagnosis of COVID-19; as well as acquisition of a more robust understanding of SARS-CoV-2 pathogenesis. Topics addressing influence and interaction of sex (a biological variable) and gender, race and ethnicity, and those addressing questions about risk, prevention, and health outcomes are also of interest.
Notice of Special Interest: Infrastructure Access for Research on Coronavirus Disease 2019 (COVID-19) Conducted in the National Dental Practice-Based Research Network
  • Due: November 2, 2020
  • Funding: Not specified
  • Project period: 1 year
  • Purpose: To fund topics of immediate and high impact to protect and ensure the safety of personnel and patients in dental practices, prevent SARS-COV-2 transmission, and improve detection and diagnosis of COVID-19. Successful X01 applicants will be given access to the National Dental PBRN infrastructure to support an individual project.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional)
  • Due: December 16, 2020
  • Funding: $250,000 per year, direct costs
  • Project period: Up to 3 years
  • Purpose: To delineate and address mechanisms by which people with diseases in the mission of NIDDK have poor outcomes from SARS-CoV-2 infection, including variable susceptibility, altered course of disease, morbidity, and mortality.

National Institute of Environmental Health Sciences (NIEHS)

Notice of Special Interest: Support for Understanding the Impact of Environmental Exposures on COVID-19 
  • Due: Monthly, through May 3, 2021
  • Project period: 1 year
  • Purpose: To promote rapid understanding of the potential contributions of current and past exposure to environmental agents that may exacerbate COVID-19 susceptibility, disease severity, and progression.
Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21)
  • Due: Monthly through October 4, 2022
  • Project period: 2 years
  • Purpose:  To understand the consequences of natural and human-made disasters, emerging environmental public health threats, and policy changes in the U.S. and abroad. Entire cycle, from submission to award, is expected to be within 3-4 months. Use this mechanism if you are applying for a new R21 grant that does not build off of an existing NIEHS grant.

National Institute of General Medical Sciences (NIGMS)

Guidance for Cost-Related Flexibilities for SCORE Award Recipients Affected by COVID-19
Notice of Special Interest: Emergency Competitive Revisions for Research on SARS-CoV-2 and COVID-19
  • Due: Rolling through February 5, 2021
  • Funding: Not more than amount of current parent award
  • Project period: 1 year
  • Purpose: To address only: 1) Incorporation of data related to SARS-CoV-2 into ongoing predictive modelling efforts for spread of SARS-CoV-2 and other related infectious agents; 2) Repurposing or modifying diagnostic tools currently under development to enable rapid detection of SARS-CoV-2 infection (SBIR/STTR grants only); 3) Rapid development of potential therapeutic agents for COVID-19 (SBIR/STTR only).

National Institute of Mental Health (NIMH)

Notice Announcing the Availability of Common Data Elements for Research Related to the Public Health Emergency caused by Coronavirus Disease 2019 (COVID-19)
  • Purpose: To reduce proliferation of one-off survey items and to facilitate data integration, collaboration, and comparisons across data sets pertaining to mental health outcomes and experiences during the COVID-19 public health emergency and exposures to the SARS-CoV-2 virus.
Notice of Special Interest: Administrative Supplements and Revision Supplements on COVID-19
  • Due: Rolling through May 1, 2021
  • Project period: 1 year, with possible second year
  • Purpose: To examine how a disrupted workforce may adequately respond/adapt to and maintain services or provide additional care for new or worsening mental health needs and/or suicide risk in midlife and older age adults will be seen as a high priority.
Notice of Special Interest: Administrative Supplements & Urgent Competitive Revisions for Mental Health Research on 2019 Novel Coronavirus
  • Due: Rolling through April 15, 2021
  • Purpose: To provide an evidence base for how a disrupted workforce may adequately respond/adapt to and maintain services or provide additional care for new or increasing mental health needs, as well as to learn about the effects of the virus and public health measures to prevent spread of COVID-19 that may have an impact on mental health. Research addressing the intersection of COVID-19, mental health, and HIV treatment and prevention are also of interest.

National Institute of Minority Health & Health Disparities (NIMHD)

Notice of Special Interest: Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health & Health Disparities
  • First due date: May 1, 2020
  • Project period: 1 year, with possible second year
  • Purpose: To highlight urgent need for research on the impact of the novel Coronavirus (SARS-CoV-2) pandemic causing COVID-19 disease outbreaks and the resulting disruptions on individual and social wellbeing, health services use, and health outcomes for NIH-designated health disparity populations.

National Institute of Neurological Disorders and Stroke (NINDS)

Notice of Special Interest: Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System
  • Due: Rolling through April 14, 2021
  • Funding: Up to $200,000 direct costs
  • Project period: Up to 1 year
  • Purpose: To highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and on biological effects on the nervous system of its causative agent, SARS-CoV-2. 

National Institute on Aging (NIA)

Notice of Special Interest: Administrative Supplements & Revision Supplements on COVID-19
  • Due: Rolling until May 1, 2021
  • Funding: Not specified
  • Project period: 1 year, with possible second year
  • Purpose: To support mission critical areas of research for NIA as they relate to the COVID-19 pandemic. Research interests are provided by the Division of Aging Biology, Division of Neuroscience, and the Division of Behavioral and Social Research.
  • FAQs here: NOT-AG-20-031
Notice of Special Interest: Administrative Supplements & Urgent Competitive Revisions for Research on Stress Management in Relation to COVID-19
  • Due: Rolling through October 6, 2020
  • Project period: Up to 2 years
  • Purpose: To address the specific needs and circumstances of midlife and older adults, including, but not limited to, individuals with Mild Cognitive Impairment, Alzheimer’s disease and Alzheimer’s disease related dementias and their healthcare providers and caregivers.
Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required)
  • Due: Monthly, through February 1, 2020
  • Funding: Not specified
  • Project period: Up to 5 years
  • Purpose: To support clinical trials of interventions focused on specific aging-related issues to reducing transmission, risk, morbidity, mortality, severity, or complications of Coronavirus Disease 2019 (COVID-19).

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Notice of Special Interest: Administrative Supplements & Urgent Competitive Revisions for Research on Stress Management COVID-19
  • Due: Rolling through October 6, 2020
  • Project period: Up to 2 years
  • Purpose: To investigate stress management strategies, including mind and body approaches, that individuals may engage in remotely to address stressors related to social distancing, as well as to address recovery and recurrence of symptoms during and after COVID-19 infections.
Notice of Special Interest: Administrative Supplements & Competitive Revision Supplements on COVID-19 Within Mission of NIAAA
  • Due: Rolling through April 15, 2021
  • Funding: Up to $100,000 per year; exceptions require permission
  • Project period: Up to 2 years
  • Purpose: To understand relationships between alcohol consumption and COVID-19 related-outcomes to enhance the nation’s response to the current pandemic.

National Institute on Drug Abuse (NIDA)

Notice of Special Interest: Administrative Supplements and Urgent Competitive Revisions for Research on COVID-19
  • Due: Rolling until April 1, 2021
  • Funding: $100,000 per year
  • Project period: 2 years
  • Purpose: To support research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders.

National Institute on Deafness and Other Communication Disorders (NIDCD)

Notice of Special Interest: NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders
  • Due: Standard dates through September 8, 2022
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To invite research on COVID-19 in relation to NIDCD’s scientific programs of hearing, balance, taste, smell, voice, speech and language (HBTSVSL).

Other Federal Funding Opportunities:

Biomedical Advanced Research & Development Authority

Broad Agency Announcement
  • Due: Rolling through October 31, 2020
  • Funding: Negotiated
  • Purpose: To explore the development of new medical countermeasures and take other actions to enhance health security in partnership with the U.S. Department of Health and Human Services and the Office of the Assistant Secretary for Preparedness and Response.
  • Additional information about BARDA
Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement
  • Due: Rolling through February 3, 2023
  • Funding: Negotiated
  • Purpose: To fund COVID-19 related research in the development of diagnostics and/or vaccines.

Department of Energy

Invitation to send research questions
  • Due: Rolling review
  • Purpose: To identify scientific questions that underpin COVID-19 response and that the research community may answer using DOE user facilities, computational resources, and enabling infrastructure.

National Aeronautics and Space Administration

Making Innovative Use of NASA Satellite Data to Address Environmental, Economic, and/or Societal Impacts of the COVID-19 pandemic
  • Due: March 29, 2021
  • Funding: $100,000
  • Project period: 1 year
  • Purpose: To address environmental, economic, and/or societal impacts of the COVID-19 pandemic.

National Council on Disability

COVID-19’s Broadscale Impact on People with Disabilities
  • Due: August 21, 2020
  • Funding: $150,000
  • Project period: Approximately 1 year
  • Purpose: To develop NCD’s annual progress report which will examine COVID-19’s broadscale impacts on the lives of people with disabilities in seven major areas. Cooperative agreement.

National Institute of Standards & Technology

NIST Manufacturing USA National Emergency Assistance Program
  • Due: October 5, 2020
  • Funding: $250,000 to $10 M
  • Project period: Not specified
  • Purpose: To invite Manufacturing USA institutes to propose high-impact projects designed to respond to the COVID-19 pandemic. Several project areas are listed.

National Science Foundation

Ecology and Evolution of Infectious Diseases
  • Due: November 18, 2020
  • Funding: Up to $2.5 M total
  • Project period: 5 years
  • Purpose: To support research on the ecological, evolutionary, and social drivers that influence the transmission dynamics of infectious diseases.
RAPID Funding Mechanism for COVID-19 Related Investigations
  • Due: Follow application type
  • Funding: Up to $200,000 via RAPID
  • Project period: Up to 1 year via RAPID
  • Purpose: To encourage submissions to existing opportunities via the RAPID funding mechanism for COVID-19-related investigations.

NSF: Office of Advanced Cyberinfrastructure

Provisioning Advanced Cyberinfrastructure to Further Research on COVID-19
  • Due: Rolling
  • Funding: Not specified
  • Purpose: To invite RAPID proposals and supplemental funding requests to existing awards that address COVID-19 challenges through data and/or software infrastructure development activities.

Patient-Centered Outcomes Research Institute

Applicant and awardee FAQs for COVID-19 projects.
PCORI Broad & Methods PFAs
  • Due: May defer submission to September 1, 2020 (Cycle 2)
  • Deferral requests due: May 5

US Agency for International Development – Bangladesh

USAID/Bangladesh and the Private Sector: Partnering to Fight COVID-19
  • Due: April 29, 2021
  • Funding: $900,000 to $10.0 M
  • Project period: Not specified
  • Purpose: To provide a medium through which organizations can work with USAID and the private sector to build Global Development Alliances (that will: a) respond to the current outbreak of COVID-19 in Bangladesh; b) address important business interests and objectives; and c) advance USAID’s strategic priorities and objectives. Interventions awarded through this program may address the immediate concerns and impacts of COVID-19 as well as long term or secondary impacts such as those on food security or the garments sector, as well as promote peace, stability, human rights, and gender equity.

US Food and Drug Administration

FDA Postgraduate COVID-19 Analysis Fellowship
  • Due: September 24, 2020
  • Funding: Not specified
  • Project period: 1 year with opportunity for renewal
  • Purpose: To provide training in computer science, bioinformatics, and/or computational biology. Most projects have a component of machine learning and the participant will learn to use these on large biological datasets, including RNA-seq. The participant will be learning bioinformatics tools to answer questions such as, translation rate of viral and host genes, analysis of polymorphisms in the population that may have predisposition to get infected, sequence analysis to design vaccine, optimization and de-optimization of viral sequences.

Non-Federal Opportunities & Consortia:

23andMe

COVID-19 Study
  • Due: Open
  • Purpose: To uncover genetic risks associated with severe outcomes of infections by SARS-CoV-2.
  • Note: Soliciting participation in a collaborative study. Contact information provided for investigators who would like to partner with 23andMe.

American Pharmacists Association Foundation

Incentive Grants for Residents and their Preceptors
  • Due: September 8, 2020
  • Funding:  $1,000
  • Project period: 1 year
  • Purpose: To support projects focusing on the following areas: COVID-19 Prevention/Treatment/Testing, Behavioral Health, Diabetes/ Cardiovascular Care, Pain Management, Patient Care Workflow, Pharmacist-Patient Communication, Pharmacogenomics.
  • Eligibility Notes: Available to residents and their preceptor.

Berytech Fab Lab

HealthTech Solutions Initiative: Prototyping Solutions for the Coronavirus Crisis
  • Due: Open
  • Funding: $10,000 for prototyping
  • Project period: Not specified
  • Purpose: To support teams working on a health technology solution including test kits, respiratory devices, protective equipment or mobile applications for detection, tracing, and information sharing, that can respond immediately to the coronavirus crisis and the current emergency medical needs for Lebanon.

Biogen

COVID-19 Relief
  • Due: Open
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To provide relief focused on the following categories: 1) expanding and ensuring access to testing, 2) easing the burden on healthcare systems and healthcare workers, 3) providing food and necessities for our most vulnerable populations.
  • Eligibility Notes: Must be a 501(c)3 organization.

Boehringer Ingelheim

IIS Program i – Established Products
  • Due: Open
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: Supporting clinical and non-clinical investigations involving COVID-19 related matters including safety, clinical outcomes, antiviral effects, or antithrombotic benefits.
  • Eligibility Notes: Applicants must be U.S. academic or community- based scientists individually or through consortia.

California Health Care Foundation

Unsolicited requests – Letter of Inquiry
  • Due: Open
  • Funding: Not specified
  • Purpose: To advance improvements in the health care delivery system for the people of California, particularly those with low incomes and those whose needs are not well served by the status quo.

Cisco Systems, Inc.

Pandemic/COVID19 Science, Technology and Social Impact
  • Due: Open
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To provide solutions ranging from predictive analytics innovative devices for saving lives to technology for devising voting machines.

Coalition for Epidemic Preparedness Innovation (CEPI)

COVID-19 Vaccines: Accelerating Vaccine Development and Global Manufacturing Capacity to Stop the Pandemic
  • Due: Rolling through September 28, 2020
  • Funding: Not specified
  • Project period: 12 to 18 months
  • Purpose:  To target organizations seeking additional support to expand their COVID-19 vaccine global development plans, having already secured resources for a vaccine candidate for a given COVID-19 target indication or region.

Cystic Fibrosis Foundation

SARS-CoV-2 and Cystic Fibrosis Research Award
  • Due: July 17, 2020 (LOI) October 1, 2020 (Application)
  • Funding: $125,000 per year
  • Project period: 2 years
  • Purpose: To improve the understanding of SARS-CoV-2 pathogenesis in cystic fibrosis via basic science research projects.
  • Eligibility Notes: Available to independent investigators; U.S. residents and non-residents.

Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)

Call for Multidisciplinary Research into Epidemics and Pandemics in Response to the Outbreak of SARS-CoV-2
  • Letter of Intent: July 1, 2020
  • Due: September 1, 2020
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To address the prevention, early detection, containment and investigation of the causes, impacts and management of epidemics and pandemics, taking the example of SARS-CoV-2 and other microorganisms and viruses that are pathogenic to humans.

Emergency Medicine Foundation

FUJIFILM SonoSite COVID-19 Point of Care Ultrasound Acceleration Research Grant RFP
  • Due: August 21, 2020
  • Funding: $30,000 (single site), $90,000 (multi-centered sites)
  • Project period: 6 months
  • Purpose: To further learn and evaluate the role of ultrasound in COVID-19.
  • Eligibility Notes: An emergency physician must be a Principal or Co-Principal Investigator.

Encephalitis Society

Encephalitis and COVID-19 Seed Funding
  • Due: August 31, 2020
  • Support: Up to 10,000 pounds
  • Project period: Up to 18 months
  • Purpose: To look at the relationship between encephalitis and Covid-19 so scientists and treating physicians can better understand this relationship and improve patient support moving forward.

Extreme Science and Engineering Discovery Environment (XSEDE)

COVID-19 HPC Consortium
  • Due: Rolling
  • Resources: Access to computing capabilities from some of the most powerful and advanced computers in the world
  • Purpose: To empower researchers around the world to accelerate understanding of the COVID-19 virus and the development of treatments and vaccines to help address infections via exceptional computational resources and collaborations. 
  • Eligibility Notes: 3 page application must describe need for high-performance computing and have high-performance computing knowledge and experience on the proposing team.

Fast Grants

Fast Funding for COVID-19 Science
  • Due: Submission is currently on pause.
  • Funding: $10,000 to $500,000
  • Project period: 6 months
  • Purpose: To expedite COVID-19-related science.
  • Eligibility Notes: Available to scientists at academic institutions currently working on COVID-19 related projects and in need of funding.

Gates Foundation

No open requests for investigator-initiated applications related to COVID-19 are available at this time. Current funding is directed to the COVID-19 Therapeutics Accelerator in collaboration with Wellcome and Mastercard, as well as targeted international efforts.

Google Cloud

COVID-19 Research Credits Program
  • Due: Open
  • Funding: Not specified, but intended to fully-fund project
  • Project period: 90 days
  • Purpose: To identify potential treatments, techniques, and datasets to impact public health. Preference given to projects that make their datasets publicly available and referenceable.

Innovations for Poverty Action

Competitive Fund for Peace and Recovery
  • Due: Rolling
  • Funding: Up to $50,000
  • Project period: Not specified
  • Purpose: To 1) directly inform the COVID-19 response; 2)evaluate interventions that are expected to improve COVID-19 response or recovery; 3) anonymize, curate, and share already-collected data quickly so that it can be used for decision-making by the humanitarian community; or 4) conduct a “downstream survey” that follows up on a sample that participated in an already-completed randomized trial in order to identify whether the intervention studied has an impact on the communities’ response to COVID-19.

International AIDS Society

CIPHER Grant Program

  • Due: October 30, 2020
  • Funding: $150,000
  • Project period: Two years
  • Purpose: The CIPHER Grant Programme directly supports the development of early-stage investigators, awarding up to US$150,000 for up to two years to address research gaps in paediatric and adolescent HIV in resource-limited settings. The 2020/2021 round will focus on service delivery for HIV and related co-infections for paediatric and adolescent populations in resource-limited settings, including research on:
    • The impact of the COVID-19 pandemic on HIV and related co-infections service delivery
    • Community interventions to improve outcomes along the HIV cascade.
  • Eligibility Note: Applicants must be fewer than 10 years out from terminal research degree and never have served as PI on a non-training grant exceeding $30,000.

Islamic World Educational, Scientific, and Cultural Organization

ICESCO Prize for Fighting Against Coronavirus
  • Due: Nominations open
  • Funding: $200,000
  • Purpose: To reward independent researcher, group of researchers, or institution for discovering effective cure or vaccine against the novel Coronavirus.

March of Dimes Foundation

2020 COVID-19 Fund
  • Due: September 4, 2020
  • Funding: $100,000 – $125,000
  • Project period: 12 months
  • Purpose: To support translational and actionable science leading directly to improved diagnosis, treatment, and ultimately prevention for mothers and infants in a pandemic climate.
  • Eligibility Notes: Available to health professionals, health researchers, epidemiologists, and social scientists with doctoral or terminal academic degrees with a faculty appointment or equivalent at academic universities, hospitals and research institutions; small businesses or startup companies in biotech and/or pharmaceuticals, committed to research in the area of maternal and child health are welcome to apply.

Merck KgaA

Research Grant for Pandemic Preparedness
  • Due: Rolling
  • Funding: Up to 500,000 euros per year
  • Project period: 3 years
  • Purpose: To leverage technological solutions to be more prepared for pandemic outbreaks or solutions that could help to fight emerging viral infections.

Mozilla

Mozilla Open Source Support (MOSS)
  • Due: Rolling with monthly review
  • Funding: $5,000 to $150,000
  • Purpose: To support open source projects creatively responding to the COVID-19 pandemic. Includes but is not limited to software, hardware, firmware, design, and networking projects. All projects must generally involve some amount of technical development.

One Young World

COVID-19 Young Leaders Fund
  • Due: Open
  • Funding: 2,500 to 10,000 pounds
  • Project period: Not specified
  • Purpose: To support young leaders who are tackling the Covid-19 pandemic on the frontlines.

Open Road Alliance

Charitable grants and loans in response to COVID-19
  • Due: Open
  • Funding: Not specified
  • Project Period: Not specified
  • Purpose: To support organizations responding directly to COVID-19 that also demonstrate how their intervention moves towards longer term adaptation and systemic/sustainable impact beyond the immediate outbreak. Not research-related.
  • Eligibility Note: Must be non-profit or registered charity.

Paul Scherrer Institut (Swiss)

Priority access call for work on combating COVID-19
  • Due: Rolling through September 2020
  • Funding: Not specified
  • Project period: Rapid launch, unspecified
  • Purpose: To contribute to the understanding of the virus and/or to improve the clinical or public health response and patient care. Explicitly requires projects that can launch within months.
  • Notes: Short proposal, rapid review. Requires DUO or PSI ID numbers. Links available to obtain.

PurSolutions

Cytoskeleton Reagent Scholarship
  • Due: Rolling, rapid review
  • Funding: Free reagents
  • Project period: Not specified, research ready to launch
  • Purpose: To provide cytoskeleton reagents for COVID research. Coronavirus spike proteins interact with cytoskeleton filaments (i.e. microtubules and actin) for internalization into host cells – a critical step in viral pathogenesis. For some coronaviruses that targeting the cytoskeleton with tubulin or actin inhibitors reduces viral load.
  • Eligibility Note: Application includes all career stages from graduate students to PIs. Brief <=5,000 character, online submission to request free reagents for COVID research.

Robert Wood Johnson Foundation

Pioneering Ideas: Exploring the Future to Build a Culture of Health
  • Due: Open
  • Funding: Not specified
  • Project period: Flexible, typically 1 to 3 years
  • Purpose: To address four areas of focus: 1) future of evidence; 2) future of social interaction; 3) future of food; 5) future of work. Proposals may choose to focus on COVID-19, directly or indirectly, but a response to the pandemic is not required.

Social Science Research Council

Just Tech COVID-19 Rapid Response Grants
  • Due: Rolling (reviews begin August 31, 2020)
  • Funding: $5,000 – $10,000
  • Project period: Not specified
  • Purpose: SSRC, as part of its Just Tech program, seeks proposals from across the social sciences and related fields that address the risks, opportunities, and challenges posed by public health surveillance stemming from the Covid-19 pandemic.
  • Eligibility: Available to academic/nonacademic researchers who hold a PhD in any social science discipline or related interdisciplinary field.

Society for Medical Decision Making

COVID Decision Modeling Initiative
  • Due: June 30, 2020
  • Funding: Up to $50,000
  • Project period: Up to 6 months
  • Purpose: To catalyze innovative COVID-19 decision models for rapid uptake and impact. The COVID Decision Modeling Initiative (CDMI) will support the development of decision models to inform the urgent needs of decision makers responding to the COVID-19 pandemic.

The Global Fund

COVID-19 Response Mechanism
  • Due: Open
  • Funding: Up to 10% of current Global Fund funding
  • Project period: Within current 2020-2022 allocation window
  • Purpose: To support countries in responding to COVID-19, mitigating the impact on programs to fight HIV, TB and malaria, and initiating urgent improvements in health and community systems.

Turkish Philanthropy Funds

TPF COVID-19 Community Relief Fund
  • Due: Rolling
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To support containment, response and recovery activities for those affected and for the responders.
  • Eligibility Notes: Currently only accepting proposals from TPF partners in Turkey. However, non-profit organizations in the US may email irem@tpfund.org to request consideration.

United States – Israel Binational Science Foundation

BSF Annual Research Grant
  • Due: November 18, 2020
  • Funding: $230,000
  • Project period: 3 years
  • Purpose: To support collaborative research by US and Israeli research teams in the areas of biomedical engineering, life sciences, medicine, psychobiology, exact physical sciences, and social sciences. Proposals related to COVID-19 in these priority areas are welcome.
  • Eligibility Notes: Applications made jointly by US and Israeli researchers. Prior collaboration not required.

VINNOVA

Innovation projects in the health field that dampen the prevalence and effects of the covid-19 pandemic
  • Due: August 18, 2020
  • Funding: Up to 5.0 M SEK
  • Project period: Not specified
  • Purpose: To fund health-related innovation projects and feasibility studies to curb the spread and effects of the COVID-19 pandemic and prevent future pandemics.
  • Note: Full call for proposals is in Swedish.

Volkswagon Foundation

Corona Crisis and Beyond
  • Due: Rolling
  • Funding: Up to 120,000 euros
  • Project period: Up to 18 months
  • Purpose: To supplement existing projects from any discipline that not only contribute directly to overcoming the crisis, but can also provide impetus for overcoming major societal challenges in the medium to long term.
  • Eligibility Notes: Open to postdoctoral researchers or professors in Germany; single or integrative joint projects (up to 3 partners), international collaborations possible.

WITH Foundation

WITH Foundation and the American Academy of Developmental Medicine and Dentistry Request for Proposals
  • Due: September 3, 2020
  • Funding: $50,000
  • Project period: 1 year
  • Purpose: To address the challenges primary care providers experience in serving adults with intellectual and developmental disabilities during pandemic and/or emergency situations.

Challenges & Innovation Accelerator Competitions

InnoCentive

(Use this link for new challenges added often.)

Joint European Disruptive Initiative

Billion Molecules Against COVID-19 JEDI Grand Challenge
  • Due: Stage 2 – August 17, 2020
  • Award: 250,000 euros
  • Purpose: To rapidly identify molecules/peptides/proteins that can block the development and/or spreading of the 2019 Novel Coronavirus (SARS-CoV-2) and stop Covid-19 related disease.
  • Note: There are 3 stages. Teams can participate in one or many.

Kaggle Challenges

(Use this link for new challenges added often.)

Toronto-Dominion Bank

2020 TD Ready Challenge
  • Due: August 13, 2020
  • Funding: $260,000 to $745,000
  • Project period: Not specified
  • Purpose: To help drive accelerated, sustained and equitable COVID-19 recovery.
  • Eligibility Notes: Available to Canadian and U.S charitable, non-profit organizations.

XPRIZE

XPRIZE Rapid Covid Testing
  • Due: August 31, 2020
  • Funding: $5,000,000
  • Project period: 6 months
  • Purpose: To develop innovative, scalable COVID-19 testing solutions that will radically change the world by providing much needed insights to help society safely reopen – and not in some distant future, but right now.
  • Eligibility Notes: Teams can be comprised of university groups, high school students, startups and innovators, small to midsize companies, families, or individuals. Because of the complex technical nature of this competition, along with its rapid timeline, XPRIZE expects most entrants will already be working on solutions. However, XPRIZE encourages any and all interested parties to apply.

Other Coronavirus Funding Compilations

See live links in the directory at the top of this post.

For details about the funding sources and compilations for which we conduct scheduled surveillance for funding opportunities, this is the working document enumerating sources and links: bit.ly/34HBOt8

Pardon the dust: these resources are always under construction and not all fields may be complete, with a priority on link accuracy.

Please suggest additions of funding opportunities in comments.

Want to live on the Edge?

Register


Join the conversation

Your email address will not be published. Required fields are marked *


Saving subscription status...

3 Comments
Enouce Ndeche says:

Hi
We are a community based organization operating in the slum areas of Nairobi,Kenya.We would really like to partner/collaborate with any interested individual/students on any reserach study regarding health.Our org uses the power and the popularity of the game of soccer to create health awareness issues.You can check us on http://www.vijanaamanipamoja.org.
Thanks as i look forward to hearing!

Eigenamin says:

Thank yu so much for this great resources!
It will be really helpful  if  the The Edge for Scholars consider another article  that focuses on postdoc/career transition  funding  opportunities in the context of covid-19 centered research.
Kind regards!

Eigenamin says:

Thank you so much for this great resource!It will be really helpful if the The Edge for Scholars consider another article that focuses on postdoc/career transition funding opportunities in the context of covid-19 centered research.Kind regards!

You May Also Like